文献速递创伤与烧伤

扩展创伤超声聚焦评估对NEXUS胸部决策工具筛查效能的影响

Effect of the Extended Focused Assessment With Sonography for Trauma on the Screening Performance of the National Emergency X-Radiography Utilization Study Chest Decision Instrument.
PubMed 文献 · Ann Emerg Med · 2023-02-07
一句话结论在NEXUS胸部决策工具中加入eFAST并未改善其筛查效能,且eFAST不能替代胸部X线预测变量。

本研究为对2011-2014年8家一级创伤中心前瞻性数据的二次分析,纳入1957例有CT、胸部X线、NEXUS临床标准及充分eFAST记录的成人钝性创伤患者,其中624例(31.9%)存在钝性胸部损伤,126例(6.4%)为主要损伤。比较加入eFAST或替换胸部X线的改良决策工具与原始NEXUS胸部决策工具的筛查效能。结果显示,加入eFAST后对主要损伤的敏感性0.98(0.94-1.00)、特异性0.28(0.26-0.30),对任何损伤的敏感性0.97(0.95-0.98)、特异性0.21(0.19-0.23),与原始工具相比无变化;替换胸部X线后对主要损伤敏感性0.93(0.87-0.97)、特异性0.31(0.29-0.34),对任何损伤敏感性0.93(0.91-0.951)较原始0.97(0.953-0.98)降低。结论认为eFAST不能改善NEXUS胸部决策工具的筛查效能,也不能替代其胸部X线标准。

要点

  • 在NEXUS胸部决策工具中加入eFAST作为预测变量,对主要损伤的敏感性0.98(0.94-1.00)、特异性0.28(0.26-0.30),与原始工具相比无变化。
  • 加入eFAST后对任何损伤的敏感性0.97(0.95-0.98)、特异性0.21(0.19-0.23),筛查效能未改善。
  • 用eFAST替换胸部X线后,对主要损伤敏感性0.93(0.87-0.97)、特异性0.31(0.29-0.34),对任何损伤敏感性0.93(0.91-0.951)较原始0.97(0.953-0.98)降低。
  • 作者结论认为eFAST不能替代NEXUS胸部决策工具中的胸部X线标准。

适用人群与场景

  • 成人钝性创伤患者,来自8家一级创伤中心的前瞻性数据(2011-2014年),且有CT、胸部X线、临床NEXUS标准及充分eFAST记录。

研究设计与关键结果

  • 研究类型:对前瞻性数据的二次分析,8家一级创伤中心,2011-2014年,纳入1957例有CT、胸部X线、临床NEXUS标准及充分eFAST的成人钝性创伤患者。
  • 624例(31.9%)存在钝性胸部损伤,126例(6.4%)为主要损伤。
  • 与NEXUS胸部决策工具相比,加入eFAST的决策工具对主要损伤的筛查效能无变化:敏感性0.98(0.94-1.00),特异性0.28(0.26-0.30)。
  • 加入eFAST的决策工具对任何损伤的筛查效能无变化:敏感性0.97(0.95-0.98),特异性0.21(0.19-0.23)。
  • 用eFAST替换胸部X线的决策工具对主要损伤的敏感性为0.93(0.87-0.97),特异性0.31(0.29-0.34),与原始工具相比无变化。
  • 用eFAST替换胸部X线的决策工具对任何损伤的敏感性为0.93(0.91-0.951),较原始工具的0.97(0.953-0.98)降低。

证据类型、等级与局限

  • 证据类型:对前瞻性数据的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,加入eFAST作为预测变量未能改善原始NEXUS胸部决策工具的诊断筛查效能,且eFAST不能替代NEXUS胸部决策工具的胸部X线标准。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: Developed to decrease unnecessary thoracic computed tomography use in adult blunt trauma patients, the National Emergency X-Radiography Utilization Study (NEXUS) Chest clinical decision instrument does not include the extended Focused Assessment with Sonography in Trauma (eFAST). We assessed whether eFAST improves the NEXUS Chest clinical decision instrument's diagnostic performance and may replace the chest radiograph (CXR) as a predictor variable.

METHODS: We performed a secondary analysis of prospective data from 8 Level I trauma centers from 2011-2014. We compared performance of modified clinical decision instruments that (1) added eFAST as a predictor (eFAST-added clinical decision instrument), and (2) replaced CXR with eFAST (eFAST-replaced clinical decision instrument), in screening for blunt thoracic injuries.

RESULTS: One thousand nine hundred fifty-seven patients had documented computed tomography, CXR, clinical NEXUS criteria, and adequate eFAST; 624 (31.9%) patients had blunt thoracic injuries, and 126 (6.4%) had major injuries. Compared to the NEXUS Chest clinical decision instrument, the eFAST-added clinical decision instrument demonstrated unchanged screening performance for major injury (sensitivity 0.98 [0.94 to 1.00], specificity 0.28 [0.26 to 0.30]) or any injury (sensitivity 0.97 [0.95 to 0.98], specificity 0.21 [0.19 to 0.23]). The eFAST-replaced clinical decision instrument demonstrated unchanged sensitivity for major injury (sensitivity 0.93 [0.87 to 0.97], specificity 0.31 [0.29 to 0.34]) and decreased sensitivity for any injury (0.93 [0.91 to 0.951] versus 0.97 [0.953 to 0.98]).

CONCLUSION: In our secondary analysis, adding eFAST as a predictor variable did not improve the diagnostic screening performance of the original NEXUS Chest clinical decision instrument; eFAST cannot replace the CXR criterion of the NEXUS Chest clinical decision instrument.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Grade MM, Ehlers PF, Kornblith AE, et al. Effect of the Extended Focused Assessment With Sonography for Trauma on the Screening Performance of the National Emergency X-Radiography Utilization Study Chest Decision Instrument. Ann Emerg Med. 2023. PMID: 36754698. doi:10.1016/j.annemergmed.2022.09.027

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。